Navigation Links
How molecules out of balance lead to human multiple myeloma and other cancers
Date:7/29/2008

An international team of scientists has identified processes that are heavily implicated in human multiple myeloma and other B cell cancers, moving us closer to developing quick tests and readouts that could help in the tailored treatment of patients.

B cells, the white blood cells that produce antibodies, form a key part of our 'immune response'. To remain healthy, we need to maintain the right number of B cells, not too many and not too few. This in turn relies on an intricate interplay of molecules within our bodies, and inside our B cells.

Professor Fabienne Mackay, Professor Klaus Rajewsky and Dr Marc Schmidt-Supprian, from Sydney's Garvan Institute of Medical Research, Harvard Medical School and Germany's Max Planck Institute of Biochemistry respectively, have identified two processes that appear to influence B cell driven cancers. Their findings are published online this week in the international journal Proceedings of the National Academy of Sciences (US).

"We already know that the over-expression or mutation of molecules known as NIK and TRAF3 in B cells is associated with human multiple myeloma," said Professor Mackay. "Our collaborative research uncovered two distinct processes involving these molecules that help explain why."

The first process involves NIK, an enzyme that acts closely with BAFF, the substance that regulates the number of B cells in our bodies. Work done previously by Professor Mackay on BAFF showed that levels correlate with B cell hyperplasia (expansion) and cancer. The current study shows that if we have too much NIK in our systems, then our B cells will also expand, and we will be prone to cancer.

The second process, associated with the first, involves TRAF3, the molecule that negatively regulates NIK.

Professor Mackay explained that in a healthy person, NIK and TRAF3 work together, helping to maintain the right number of B cells for survival. "But when there are muta
'/>"/>

Contact: Alison Heather
a.heather@garvan.org.au
61-292-958-128
Research Australia
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New class of RNA molecules may be important in human cancer
2. Study Describes Molecules That Control Blood Pressure
3. Researchers identify molecules with interesting anti-clotting properties
4. Major Advance in the Observation of DNA Molecules
5. Molecules can block breast cancers ability to spread
6. Tiny RNA Molecules Control Breast Cancers Spread
7. Molecules might identify high-risk acute-leukemia patients
8. Molecules may help predict survival in liver cancer
9. Novel molecules developed at UB can boost vaccine potency
10. New understanding of how big molecules bind will lead to better drugs, synthetic organic materials
11. Allergic response tied to lipid molecules in cell membrane
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... 2014 Four hospitals affiliated with the ... the latest ranking of the country’s best hospitals by ... online today and slated for publication in August, the ... Hospital (AGH), Forbes Hospital, Saint Vincent Hospital and West ... clinical specialties. , “There is no higher ...
(Date:7/23/2014)... Kathleen Doheny HealthDay Reporter ... surgery appears to have an additional side benefit -- ... to a new study. The study found that ... reported having incontinence prior to the procedure. After surgery, ... improved or disappeared, said study researcher Dr. Leslee Subak, ...
(Date:7/23/2014)... -- For patients infected with both HIV and hepatitis ... viruses, a small study suggests. Researchers said doctors ... people with the two diseases. "The findings ... important role in the management of individuals with [hepatitis ... Sherman, a professor of medicine at the University of ...
(Date:7/23/2014)... a massive effort to catalog the molecular causes ... Cancer Institute, have identified four subtypes of tumors ... They say the new classification promises to advance ... third-leading cancer killer worldwide. , In a report ... Genome Atlas Research Network said they analyzed 295 ...
(Date:7/23/2014)... cancer genes have been focused on the regions of ... in the form of amino acids thus proteins. But ... or activator which controls the expression and activity of ... of the role exerted such DNA fragment in tumor ... Nature in collaboration with the group of Manel ...
Breaking Medicine News(10 mins):Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 2Health News:Four Allegheny Health Network Hospitals Named High Performers by U.S. News 3Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 2Health News:Weight Loss Surgery May Help Ease Urinary Incontinence 3Health News:HIV Meds May Also Help Control Hepatitis C, Study Finds 2Health News:New view of stomach cancer could hasten better therapies 2Health News:New view of stomach cancer could hasten better therapies 3
... ... ... ... ...
... ... ... ... ...
... ... Weight-Control Formulas: Licorice Flavonoid Oil. Licorice Flavonoid Oil is a “nutrigenomic” supplement, meaning it ... ... -- Nutrigenomics is the study of how foods affect genetics and how individual genetic ...
... kept cancer from spreading in mice, researchers say , FRIDAY, ... the spread of the cancer in mice, a new study ... mice with breast cancer. Both involve applying a cold probe ... 30 seconds) of the tumor, while the other takes a ...
... ... ... , ... , , ...
... ... ... ... ...
Cached Medicine News:Health News:Donations Sought for Chilean Relief, Children's Clinics 2Health News:Donations Sought for Chilean Relief, Children's Clinics 3Health News:Donations Sought for Chilean Relief, Children's Clinics 4Health News:Donations Sought for Chilean Relief, Children's Clinics 5Health News:Donations Sought for Chilean Relief, Children's Clinics 6Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 2Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 3Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 4Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 5Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 6Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 7Health News:Poniard Pharmaceuticals Presents Positive Survival Data from a Phase 2 Clinical Study of Picoplatin in Metastatic Prostate Cancer at the 2010 American Society of Clinical Oncology Genitourinary Cancers Symposium 8Health News:Licorice Flavonoid Oil with Glavonoid™ Added to the Swanson Health Products' Swanson Best Weight-Control Formulas 2Health News:Freezing Technique May Stop Breast Cancer 2Health News:New Mexico Cigarette Tax Increase Delivers Victory for Kids and Taxpayers, But Increase Needs to Be Permanent 2Health News:New Mexico Cigarette Tax Increase Delivers Victory for Kids and Taxpayers, But Increase Needs to Be Permanent 3Health News:New Mexico Cigarette Tax Increase Delivers Victory for Kids and Taxpayers, But Increase Needs to Be Permanent 4Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 2Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 3Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 4Health News:Merriman Curhan Ford Acted as Co-Manager in Anthera's Public Offering of Common Stock 5
(Date:7/23/2014)... -- Lightlake Therapeutics Inc. ("Lightlake") (OTCQB: LLTP), a biopharmaceutical ... in opioid antagonists, announced today that it has ... respect to its naloxone-based opioid overdose reversal nasal ... received an additional commitment from the National Institute ... Institutes of Health ("NIH"), to fund a second ...
(Date:7/23/2014)... , July 23, 2014  Silk Road ... the transcarotid treatment of intra- and extra-cranial cerebrovascular ... P. Wallace to the position of Chief ... lead the company,s Research and Development efforts across ... Prior to joining Silk Road ...
(Date:7/23/2014)... 23, 2014  ACON Equity Partners III, L.P., a ... ("ACON") announced it has completed the purchase of Injured ... Group and Parthenon Capital Partners. IWP is a leading ... Compensation, Automobile Personal Injury Protection and Personal Injury pharmacy ... As part of this transaction, ACON ...
Breaking Medicine Technology:Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 2Lightlake Therapeutics Inc. Files Investigational New Drug Application For Naloxone Nasal Spray For Reversing Opioid Overdose And Announces A Further Collaboration With The National Institute On Drug Abuse 3Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3ACON Investments Acquires Injured Workers Pharmacy 2ACON Investments Acquires Injured Workers Pharmacy 3
... Pharmaceuticals, Inc. (NYSE Amex: ANX ) today announced ... offer and sell shares of its common stock and warrants ...  The Company also intends to grant the underwriters a 45-day ... shares and warrants sold in the public offering to cover ...
... Food and Drug Administration has licensed HEMACORD™ (Hematopoietic ... cell transplantation, the first such approval of a ... According to the Food and Drug Administration,s ... is "indicated for use in unrelated donor hematopoietic ...
Cached Medicine Technology:ADVENTRX Announces Public Offering of Stock 2ADVENTRX Announces Public Offering of Stock 3FDA Approves New York Blood Center's HEMACORD™ for Stem Cell Transplantation 2FDA Approves New York Blood Center's HEMACORD™ for Stem Cell Transplantation 3
... "mobile operating table" literally! The Alphastar 1132 with ... a general purpose operating table - is as ... a cable connected hand control, an IR-hand control ... is a control panel at the top of ...
... introduce the Cmax operating table that combines ... surgical table with the radiolucence and precise ... the most advanced, versatile surgical table on ... to support advancements in surgical procedures and ...
... The state-of-the-art Opus II urology imaging table ... enhanced patient access, exceptional imaging and advanced ... has the smallest footprint in the industry ... anesthesiologist and can be changed to either ...
Inquire...
Medicine Products: